top of page

Our Team

​

michael headshot.png

Michael Jay, Ph. D.

  • LinkedIn

Founder

40+ years in drug development, formulations, and imaging agents. Fred Eshelman Chair & Emeritus Professor (retired) of molecular pharmaceuticals at UNC Chapel Hill.

unnamed.jpg

Jeffrey Miller

Chairman and Chief Executive Officer 

  • LinkedIn

>30 years in biopharma industry: Eli Lilly, Boehringer Ingelheim, Alexion, Alnylam. Worked in over 20 countries; lived abroad for 25% of career. Co-founder of TSP Therapeutics.

Alanheadshots2023-10_edited.jpg

Alan Parr, Pharm. D., Ph. D.

  • LinkedIn

Chief Technical Officer

35+ Years in pharmaceutical industry; involved with numerous FDA and EMA regulatory submissions. Principal Investigator on Phase 2 SBIR grant.

shannon pic.png

Shannon Wallet, Ph. D.

  • LinkedIn

Chief Scientific Officer

Chair and Professor, Dept of Oral Biology, College of Dentistry, University of Florida. Contributed to 100+ academic papers/articles/ textbooks. Served as Associate Dean for Dental Research & Director of Dental Clinical Research Units for 5+ years.

kevin pic.jpeg

Kevin Byrd, DDS., Ph. D. 

  • LinkedIn

Advisor

DDS, University of Michigan. Ph. D., Oral and Craniofacial Biomedicine, UNC. Volpe Research Scholar. Manager of Oral & Craniofacial Research, American Dental Association Science & Research Institute. 

019.jpeg

Alexandra Miller

  • LinkedIn

Intern

Junior at Hobart & William Smith Colleges double majoring in Economics and Biology to prepare for career in biopharma. 

bottom of page